Case number 2017-1444
Endo Pharmaceuticals Inc. v. Amneal Pharmaceuticals LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 15, 2018 | 30 | ORDER filed. Teva's motion [498338-2] is granted only to the extent that 2017-1444 is withdrawn. Amneal's motion [498221-2] is granted only to the extent that 2017-1094 is withdrawn. Each party shall bear its own costs in 2017-1444 and 2017-1094. The revised official caption for 2017-1240, -1455, -1887 is reflected in the order. The parties are directed to file new briefs in 2017-1240, -1455, -1887, limited to the matters now on appeal. Endo's opening brief is due no later than April 6, 2018. Appellees' response briefs are due no later than April 20, 2018. Endo’s reply brief and the joint appendix are due no later than April 27, 2018. ISSUED AS A MANDATE (as to 2017-1444 and 2017-1094 only): March 15, 2018. Service: 03/15/2018 by clerk. [505691] [17-1240, 17-1444, 17-1094] [LMS] [Entered: 03/15/2018 04:10 PM] (4) |
| Apr 12, 2017 | 28 | ORDER consolidating appeals (17-1887 with 17-1094, -1240, -1444, -1455). The revised official caption is reflected in the order. Endo Pharmaceuticals Inc.'s opening brief addressing all of these appeals, and Mallinckrodt LLC's response brief addressing only issues associated with 17-1094, -1240, -1444, -1455, are due no later than 05/01/2017. Amneal Pharmaceuticals LLC et al.'s response/reply brief, addressing only issues associated with 17-1094, -1240, -1444, -1455, and Actavis LLC et al.'s response brief, addressing only issues associated with 17-1887, are due no later than 06/12/2017. Endo's reply brief is due no later than 06/26/2017. Service as of this date by Clerk of Court. [423414] [17-1094, 17-1240, 17-1444, 17-1455, 17-1887] [MJL] [Entered: 04/12/2017 11:52 AM] (2) |
| Apr 12, 2017 | 29 | Note to file: The following cases are consolidated: 17-1094 (Lead) with 17-1240, -1444, -1455, -1887 (Members). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [423608] [17-1094, 17-1240, 17-1444, 17-1455, 17-1887] [MJL] [Entered: 04/12/2017 04:33 PM] (0) |
| Mar 10, 2017 | 26 | ORDER granting motion to consolidate appeals [25] filed by Cross-Appellant Endo Pharmaceuticals Inc. and Appellee Mallinckrodt LLC; The revised official caption is reflected in the order. Because the appeals are consolidated, one set of briefs should be filed for the appeals.; Teva Pharmaceuticals USA, Inc. and Barr Laboratories, Inc.’s opening brief is due no later than 03/20/2017. Endo's principal/response brief and Mallinckrodt’s response brief are due no later than 05/01/2017. The appellants’ response/reply briefs are due no later than 06/12/2017. Endo's reply brief is due no later than 06/26/2017. Service: 03/10/2017 by clerk. [414313] [NL] [Entered: 03/10/2017 11:33 AM] (2) |
| Mar 10, 2017 | 27 | Note to file: The following cases are associated:17-1094 Lead with 17-1240, 17-1444, 17-1455 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [414391] [17-1094, 17-1240, 17-1444, 17-1455] [JCA] [Entered: 03/10/2017 01:13 PM] (0) |
| Mar 3, 2017 | 25 | MOTION of Appellee Mallinckrodt LLC and Cross-Appellant Endo Pharmaceuticals Inc. to consolidate appeals (2017-1094, -1240 with 2017-1444, -1455). Any response is due within 10 days of service [Consent: unopposed]. Service: 03/03/2017 by email. [412386] [Sharon Gagliardi] [Entered: 03/03/2017 01:59 PM] (11) |
| Feb 27, 2017 | 24 | ORDER granting motion to extend time to file appellants' principal brief [23] filed by Appellants Barr Laboratories, Inc. and Teva Pharmaceuticals USA, Inc.. The brief is due 03/20/2017. Service as of this date by Clerk of Court. [410942] [MJL] [Entered: 02/27/2017 03:38 PM] (2) |
| Feb 24, 2017 | 23 | MOTION of Appellants Barr Laboratories, Inc. and Teva Pharmaceuticals USA, Inc. to extend the time to 03/20/2017 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: partial consent]. Service: 02/24/2017 by email. [410585] [Huiya Wu] [Entered: 02/24/2017 04:38 PM] (9) |
| Jan 24, 2017 | 22 | Transcript Purchase Order Form for the Appellants Barr Laboratories, Inc. and Teva Pharmaceuticals USA, Inc. indicating that a request is made to the reporter for a transcript. Service: 01/25/2017 by clerk. [401812] [MJL] [Entered: 01/25/2017 12:17 PM] (2) |
| Jan 18, 2017 | 12 | Entry of appearance for Jeffrey J. Toney as principal counsel for Appellee Mallinckrodt LLC. Service: 01/18/2017 by email. [399903] [Jeffrey Toney] [Entered: 01/18/2017 11:52 AM] (2) |
| Jan 18, 2017 | 13 | Entry of appearance for Rodney R. Miller as of counsel for Appellee Mallinckrodt LLC. Service: 01/18/2017 by email. [399913] [Rodney Miller] [Entered: 01/18/2017 11:56 AM] (2) |
| Jan 18, 2017 | 14 | Entry of appearance for Paul G. Williams as of counsel for Appellee Mallinckrodt LLC. Service: 01/18/2017 by email. [399918] [Paul Williams] [Entered: 01/18/2017 11:59 AM] (2) |
| Jan 18, 2017 | 15 | Certificate of Interest for the Appellee Mallinckrodt LLC. Service: 01/18/2017 by email. [399921] [Jeffrey Toney] [Entered: 01/18/2017 12:02 PM] (3) |
| Jan 18, 2017 | 16 | Docketing Statement for the Appellee Mallinckrodt LLC. Service: 01/18/2017 by email. [399923] [Jeffrey Toney] [Entered: 01/18/2017 12:04 PM] (4) |
| Jan 18, 2017 | 17 | Entry of appearance for Huiya Wu as principal counsel for Appellants Barr Laboratories, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 01/18/2017 by email. [400171] [Huiya Wu] [Entered: 01/18/2017 04:28 PM] (2) |
| Jan 18, 2017 | 18 | Certificate of Interest for the Appellants Barr Laboratories, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 01/18/2017 by email. [400178] [Huiya Wu] [Entered: 01/18/2017 04:32 PM] (2) |
| Jan 18, 2017 | 19 | Docketing Statement for the Appellants Barr Laboratories, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 01/18/2017 by email. [400183] [Huiya Wu] [Entered: 01/18/2017 04:33 PM] (4) |
| Jan 18, 2017 | 20 | Entry of appearance for Brian J. Robinson as of counsel for Appellants Barr Laboratories, Inc. Teva Pharmaceuticals USA, Inc. Service: 01/18/2017 by email. [400188]--[Edited 01/19/2017 by clerk to add additional party filer] [Brian Robinson] [Entered: 01/18/2017 04:37 PM] (2) |
| Jan 18, 2017 | 21 | Entry of appearance for Brigid M. Morris as of counsel for Appellants Barr Laboratories, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 01/18/2017 by email. [400190] [Brigid Morris] [Entered: 01/18/2017 04:42 PM] (2) |
| Jan 12, 2017 | 5 | Certificate of Interest for the Cross-Appellant Endo Pharmaceuticals Inc.. Service: 01/12/2017 by email. [398183] [Sharon Gagliardi] [Entered: 01/12/2017 11:59 AM] (3) |
| Jan 12, 2017 | 6 | Docketing Statement for the Cross-Appellant Endo Pharmaceuticals Inc.. Service: 01/12/2017 by email. [398184] [Sharon Gagliardi] [Entered: 01/12/2017 12:00 PM] (4) |
| Jan 12, 2017 | 7 | Entry of appearance for Martin J. Black as principal counsel for Cross-Appellant Endo Pharmaceuticals Inc.. Service: 01/12/2017 by email. [398185] [Sharon Gagliardi] [Entered: 01/12/2017 12:01 PM] (2) |
| Jan 12, 2017 | 8 | Entry of appearance for Jonathan D.J. Loeb as of counsel for Cross-Appellant Endo Pharmaceuticals Inc.. Service: 01/12/2017 by email. [398187] [Sharon Gagliardi] [Entered: 01/12/2017 12:01 PM] (2) |
| Jan 12, 2017 | 9 | Entry of appearance for Blake B. Greene as of counsel for Cross-Appellant Endo Pharmaceuticals Inc.. Service: 01/12/2017 by email. [398189] [Sharon Gagliardi] [Entered: 01/12/2017 12:02 PM] (2) |
| Jan 12, 2017 | 10 | Entry of appearance for Robert D. Rhoad as of counsel for Cross-Appellant Endo Pharmaceuticals Inc.. Service: 01/12/2017 by email. [398192] [Sharon Gagliardi] [Entered: 01/12/2017 12:03 PM] (2) |
| Jan 12, 2017 | 11 | Entry of appearance for Sharon K. Gagliardi as of counsel for Cross-Appellant Endo Pharmaceuticals Inc.. Service: 01/12/2017 by email. [398194] [Sharon Gagliardi] [Entered: 01/12/2017 12:04 PM] (2) |
| Jan 6, 2017 | 2 | Note to file: 17-1444 (COMPANION started 01/06/2017) with 17-1094, -1240. These cases shall be considered companion cases and assigned to the same merits panel for oral argument. [396685] [17-1094, 17-1444] [MJL] [Entered: 01/06/2017 11:12 AM] (0) |
| Jan 6, 2017 | 3 | Note to file: The following cases are consolidated: 17-1444 (Lead) with 17-1455 (Cross-Appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [396776] [17-1444, 17-1455] [MJL] [Entered: 01/06/2017 02:14 PM] (0) |
| Jan 6, 2017 | 4 | Official caption revised to reflect cross-appeal. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [396779] [MJL] [Entered: 01/06/2017 02:15 PM] (0) |
| Jan 4, 2017 | 1 | Appeal docketed. Received: 01/03/2016. [395965]Entry of Appearance due 01/18/2017. Certificate of Interest due 01/18/2017. Docketing Statement due 01/18/2017. Appellants' brief due 03/06/2017. [MJL] [Entered: 01/04/2017 10:12 AM] (29) |
